Adimab, LLC

adimab.com

Adimab is the leading provider of biologics discovery and engineering, specializing in antibodies and multispecifics. With over 500 therapeutic programs developed through 15 years of industry partnerships, Adimab utilizes a proprietary yeast-based platform to generate high-quality therapeutic leads, including IgGs and single domain antibodies. Their focus on collaboration and innovation positions them as a key player in the biologics market, enabling partners to rapidly expand their pipelines with remarkable specificity and developability profiles.